Oxygen Biotherapeutics Files FY2010 Annual Report on Form 10-K - MarketWatch (press release)
Posted by admin / Under PerfluorocarbonOxygen Biotherapeutics Files FY2010 Annual Report on Form 10-K MarketWatch (press release) The company has developed a proprietary perfluorocarbon (PFC) which is used in the Oxycyte(R) therapeutic oxygen carrier and liquid ventilation product that ... |
Published on Friday 30th of July 2010 06:07:37 AM
Read more...
Sanguine Announces Significant PHER-O2 Order - MarketWatch (press release)
Posted by admin / Under PerfluorocarbonSanguine Announces Significant PHER-O2 Order MarketWatch (press release) The University is considered to be one of the foremost research institutions in the United States with groundbreaking work using perfluorocarbons (PFCs). ... |
Published on Friday 30th of July 2010 06:07:37 AM
Read more...
QualityStocks: QualityStocks News - Sanguine Corp. (SGUI.OB) Receives Notable ... - Trading Markets (press release)
Posted by admin / Under PerfluorocarbonQualityStocks: QualityStocks News - Sanguine Corp. (SGUI.OB) Receives Notable ... Trading Markets (press release) VCU is nationally recognized for its research in groundbreaking work using perfluorocarbons (PFCs); applications of perfluorocarbons include eye surgery, ... |
Published on Friday 30th of July 2010 06:07:37 AM
Read more...
Petacchi keeps quiet over doping investigation - Times of India
Posted by admin / Under Perfluorocarbon![]() Reuters UK | Petacchi keeps quiet over doping investigation Times of India ... quoting informed sources, previously alleged that two banned substances were found at the 36-year-old's home - PFC (Perfluorocarbon), an alternative to ... Petacchi keeps quiet on doping charges Petacchi interviewed by police over doping issue, but refuses to talk |
Published on Friday 30th of July 2010 06:07:37 AM
Read more...
Sanguine Announces Significant PHER-O2 Order - PR-USA.net (press release)
Posted by admin / Under Perfluorocarbon
Published on Friday 30th of July 2010 06:07:37 AM
Read more...




